Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 331-338

  Heijnen, Ingmar A F M ^a   Van Vugt, Martine J ^a   Fanger, Neil A ^b   Graziano, Robert F ^c   De Wit, Ton P M ^a   Hofhuis, Frans M A ^a,d   Guyre, Paul M ^b   Capel, Peter J A ^a   Verbeek, Joseph S ^a,d   Van De Winkel, Jan G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c MEDAREX INC   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

adjuvant; antigen presentation; Fc receptor; IgG; phagocytosis

Indexed keywords

BISPECIFIC ANTIBODY; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VACCINE;

ACCESSORY CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; EFFECTOR CELL; IMMUNIZATION; IMMUNOSTIMULATION; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE;

EID: 13344259328     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118420     Document Type: Article

References (38)

1. Van de Winkel, J G J., and P. J A. Capel 1993. Human IgG Fc receptors heterogeneity: molecular aspects and clinical implications. Immunol Today. 14:215-221.
2. Van de Winkel, J G. J., and C. L. Anderson. 1991. Biology of human immunoglobulin G Fc receptors J Leukocyte Biol 49:511-524
3. Valerius, T., R. Repp, T. P. M. de Wit, S Berthold, E. Platzer. J R Kalden, M. Gramatzki, and J. G. J. van de Winkel. 1993 Involvement of the high-affinity receptor for IgG (FcγRI: CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 82:931-939.
4. Kerst, J. M., J. G. J. van de Winkel, A. H Evans. M de Haas. I. C. M. Slaper-Cortenbach, T. P M. de Wit, A. E. G Kr. von dem Borne, E van der Schoot, and R. M. J. van Oers. 1993. Granulocyte colony-stimulating factor induces hFcγRI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood 81 1457-1464.
5. Te Velde, A. A., R. J. F. Huijbens, J E. de Vries, and C. G. Figdor. 1990. IL-4 decreases FcγR membrane expression and FeγR-mediated cytotoxic activity of human monocytes. J. Immunol. 144:3046-3051.
6. Te Velde, A. A , R. de Waal Malefijt, R. J. F. Huijbens, J. E. de Vries, and C. G. Figdor. 1992. IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity: distinct regulation of ADCC by IFN-γ, IL-4, and IL-10. J. Immunol 149:4048-4052.
7. De Waal Malefijt, R , C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennet, J Culpepper, W. Dang, G. Zurawski, and J. E. de Vries 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 151:6370-6381.
8. Anderson, C. L., L. Shen, D. M. Eicher, M. D. Wewers. and J. K. Gill. 1990. Phagocytosis mediated by three distinct Fcγ receptor classes on human leukocytes. J. Exp Med. 171.1333-1346.
9. Gosselin, E. J., K. Wardwell, D. R. Gosselin, N. Alter, J. L. Fisher, and P. M. Guyre. 1992. Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens. J. Immunol. 149:3477-3481.
10. Warren, H. S., F. R. Vogel, and L. A. Chedid. 1986. Current status of immunological adjuvants. Annu. Rev. Immunol. 4:369-388.
11. Van de Winkel, J. G J., L. K. Ernst, C. L. Anderson, and I. M. Chiu. 1991. Gene organization of the human high affinity receptor for IgG, FcγRI (CD64). J. Biol. Chem 266:13449-13455.
12. Taketo, M., A. C. Schroeder, L E Mobraaten, K. B. Gunning, G. Harten, R. R. Fox, T. H. Roderick, C. L. Stewart, F. Lilly, C. T. Hansen, and P. A. Overbeek. 1991. FVB/N: an inbred mouse strain preferable for transgenic analyses Proc. Natl Acad. Sci. USA. 88:2065-2069.
13. Sambrook, J., E. F. Fritsch. and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Allen, J. M., and B. Seed 1989. Isolation and expression of functional high-affinity Fc receptor cDNAs. Science (Wash. DC). 243:378-381.
15. Graziano, R. F., P. R. Tempest, P. White, T. Keler, Y. Deo, H. Ghebremariam, K. Coleman, L. C. Pfefferkorn, M. W. Fanger, and P. M Guyre. 1995. Construction and characterization of a humanized anti-γ-Ig receptor type I (FcγRI) monoclonal antibody. J. Immunol. 155:4996-5002.
16. Riechmann, L., M. Clark, H. Waldmann, and G. Winter. 1988. Reshaping human antibodies for therapy. Nature (Lond.). 332-323-327.
17. Guyre, P. M., R. F. Graziano, B. A. Vance, P. M. Morganelli, and M. W. Fanger. 1989. Monoclonal antibodies that bind to distinct epitopes on FcγRI are able to trigger receptor function. J. Immunol. 143:1650-1655.
18. Van den Herik-Oudijk, I. E., N. A. C. Westerdaal, N. V. Henriquez, P. J. A. Capel. and J. G J. van de Winkel. 1994. Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes. J Immunol. 152-574-588.
19. Pearse, R. N., R. Feinman, and J. V. Ravetch. 1991. Characterization of the promoter of the human gene encoding the high affinity IgG receptor: transcriptional induction by γ-interferon is mediated through common DNA response elements Proc. Natl. Acad. Sci. USA. 88.11305-11309.
20. Perez, C., J. Wietzerbin, and P. D. Benech. 1993. Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-γ) activation of the human high-affinity Fcγ receptor gene: a novel IFN regulatory mechanism. Mol. Cell. Biol 13:2182-2192.
21. Osman, N., C. A. Kozak, I. F. C. McKenzie, and P. M. Hogarth. 1992. Structure and mapping of the gene encoding mouse high affinity FcγRI and chromosomal location of the human FcγRI gene. J. Immunol. 148:1570-1575.
22. Skalnik, D. G., D. M. Dorfman, A. S. Perkins, N. A. Jenkins, N. G Copeland, and S. H. Orkin. 1991. Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc. Natl. Acad. Sci. USA. 88:8505-8509.
23. Grisolano, J L., G. M. Sclar, and T. J. Ley. 1994. Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad. Sci USA. 91:8989-8993.
24. Wallace, P. K., A. L Howell, and M. W. Fanger. 1994 Role of Fcγ receptors in cancer and infectious disease. J. Leukocyte Biol. 55:816-826.
25. Pfefferkorn, L. C., and M W. Fanger. 1989. Transient activation of the NADPH oxidase through FcγRI. oxidase deactivation precedes internalization of cross-linked receptors. J. Immunol. 143:2640-2649.
26. Takai, T., M. Li, D Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcR γ chain deletion results in pleiotiopic effector cell defects. Cell 76:519-529.
27. Skalnik, D. G., E. C Strauss, and S. H. Orkin. 1991. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem. 266:16736-16744.
28. Pahl, H. L., A. G Rosmarin, and D. G. Tenen. 1992. Characterization of the myeloid-specific CD11b promoter, Blood. 79:865-870.
29. Sadowski, H. B., K. Shuai, J. E. Darnell, Jr., and M. Z Gilman. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science (Wash. DC) 261:1739-1744.
30. Larner, A. C., M. David, G. M. Feldman, K.-I. Igarashi, R. H. Hackett, D. S. A. Webb, S. M. Sweitzer, E. F. Petricoin, III, and D. S. Fmbloom. 1993. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science (Wash. DC) 261:1730-1733.
31. Simms, H. H., M. M. Frank, T. C. Quinn, S. Holland, and T. A. Gaither. 1989. Studies on phagocytosis in patients with acute bacterial infections. J. Clin. Invest. 83:252-260.
32. Olweus, J., F. Lund-Johansen, and L. W. M. M. Terstappen. 1995. CD64/FcγRI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells. Blood. 85:2402-2413.
33. Rodewald, H. R., P. Moingeon, J. L. Lucich, C. Dosiou, P. Lopez, and E. L. Reinherz. 1992. A population of early fetal thymocytes expressing FC-γRII/III contains precursors of T lymphocytes and natural killer cells. Cell 69:139-150.
34. Sandor, M., J. Galon, L. Takacs, Y Tatsumi, A. L. Mueller, C. Sautes. and R. G. Lynch. 1994. An alternative Fcγ-receptor ligand: potential role in T-cell development. Proc. Natl. Acad Sci USA 91.12857-12861.
35. Ra, C., M. H. Jouvin, U. Blank, and J. P. Kinet. 1989. A macrophage Fcγ receptor and the mast cell receptor for IgE share an identical subunit. Narure (Lond.). 341:752-754.
36. Dombrowicz, D., V. Flamand, K. K. Brigman, B. H. Koller, and J. P Kinet. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell. 75 969-976.
37. Kenney, J. S., B. W. Hughes, M. P Masada, and A. C. Allison. 1989. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol. Methods. 121:157-166.
38. Tax, W. J. M, and J. G. J. van de Winkel. 1990. Fcγ receptor II a standby receptor activated by proteolysis. Immunol. Today. 11:308-310.